It has already cancelled investments in Liverpool and Cambridge, while muttering darkly about moving its listing to New York and its headquarters to the United States. Now AstraZeneca, the UK’s largest pharmaceutical company, is threatening to stop investing in Britain completely if the country does not spend more on medicine. There may be an element of arm-twisting in that, and the NHS is so stretched for cash it can’t easily spend much more on drugs. And yet, the UK also can’t afford to lose a company as significant as AZ. And if that means the NHS spending more on pills, and less on salaries, that is a choice worth making.

If that means the NHS spending more on pills, and less on salaries, that is a choice worth making.

For a company that is meant to be a national champion AZ has a ve

See Full Page